PlantForm gets more funding for HIV antibodies Guelph Mercury GUELPH — The second phase of PlantForm's development of antibodies for human immunodeficiency virus (HIV) has received a significant second round of funding from the National Research Council of Canada. The local company is progressing on a ... |
